Pluri Inc.

PLUR | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.24

+$0.04 (+3.33%)

At close: Oct 30, 2026, 4:00 PM ET

$1.22

-$0.02 (-1.61%)

After-hours: Oct 30, 2026, 5:27 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+3.33%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

42.5

-4.5 pts

Fundamentals Average

Market Sentiment Neutral

Moat None

Sector Rank #468/1028 (Top 46%)

Full Analysis

Key Statistics

Market Data

Market Cap $13.38M

1D Range

1.20 1.31

52W Range

0.85 4.45

Valuation (TTM)

PE -0.51

PB -0.58

EV/EBITDA -1.69

Valuation (NTM)

Forward PE N/A

Forward PEG 0.02

Price Target $12.00

Cash Flow

FCF Yield -151.1%

SBC Adj. FCF Yield -179.0%

SBC Impact -18.4%

Margins

Gross Margin 44.6%

Operating Margin -2455.9%

FCF Margin -1990.3%

Growth (CAGR)

Revenue 3Y | 5Y 52.4% | 40.8%

Dil EPS 3Y | 5Y 22.4% | 34.2%

FCF 3Y | 5Y -4.8% | 13.8%

Returns

ROA -98.3%

ROE 144.6%

ROIC -121.1%

Financial Health

Net Debt

$19.63M

Current Ratio 0.27

Interest Coverage -26.77

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Pluri Inc., a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range ...

Sector Healthcare

Industry Biotechnology

Employees 92

IPO Date Jun 30, 2003

Website www.pluri-biotech.com

Fiscal Year July - June

Full Company Profile

Latest News

No news articles available yet.